Jessica A Cottrell

Dr. Jessica A Cottrell

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in Materials
Verified
Journal Article
Open access
PDF file
JOJ. Patrick O'Connor
J. Patrick O'Connor
DKDeboleena Kanjilal
Deboleena Kanjilal
MTMarc Teitelbaum
Marc Teitelbaum
SLSheldon S. Lin
Sheldon S. Lin
Jessica A CottrellJessica A Cottrell
Jessica A Cottrell
Zinc is an essential mineral that is required for normal skeletal growth and bone homeostasis. Furthermore, zinc appears to be able to promote bone regeneration. However, the cellular and molecular pathways through which zinc promotes bone growth, homeostasis, and regeneration are poorly understood. Zinc can positively affect chondrocyte and osteoblast functions, while inhibiting osteoclast activity, consistent with a beneficial role for zinc in bone homeostasis and regeneration. Based on the effects of zinc on skeletal cell populations and the role of zinc in skeletal growth, therapeutic approaches using zinc to improve bone regeneration are being developed. This review focuses on the role of zinc in bone growth, homeostasis, and regeneration while providing an overview of the existing studies that use zinc as a bone regeneration therapeutic.

1 December 2016 in Foot and Ankle Clinics
Verified
Journal Article
Closed access
Jessica A CottrellJessica A Cottrell
Jessica A Cottrell
JTJessica Cardenas Turner
Jessica Cardenas Turner
TATreena Livingston Arinzeh
Treena Livingston Arinzeh
JOJ. Patrick O’cOnnor
J. Patrick O’cOnnor

8 August 2017 in Viruses
Verified
Journal Article
Open access
PDF file
DNDaniel Nichols
Daniel Nichols
WMWilliam De Martini
William De Martini
Jessica A CottrellJessica A Cottrell
Jessica A Cottrell
Cells have multiple means to induce apoptosis in response to viral infection. Poxviruses must prevent activation of cellular apoptosis to ensure successful replication. These viruses devote a substantial portion of their genome to immune evasion. Many of these immune evasion products expressed during infection antagonize cellular apoptotic pathways. Poxvirus products target multiple points in both the extrinsic and intrinsic apoptotic pathways, thereby mitigating apoptosis during infection. Interestingly, recent evidence indicates that poxviruses also hijack cellular means of eliminating apoptotic bodies as a means to spread cell to cell through a process called apoptotic mimicry. Poxviruses are the causative agent of many human and veterinary diseases. Further, there is substantial interest in developing these viruses as vectors for a variety of uses including vaccine delivery and as oncolytic viruses to treat certain human cancers. Therefore, an understanding of the molecular mechanisms through which poxviruses regulate the cellular apoptotic pathways remains a top research priority. In this review, we consider anti-apoptotic strategies of poxviruses focusing on three relevant poxvirus genera: Orthopoxvirus, Molluscipoxvirus, and Leporipoxvirus. All three genera express multiple products to inhibit both extrinsic and intrinsic apoptotic pathways with many of these products required for virulence.

28 January 2020 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
JMJames McCauley
James McCauley
CBConstantine Bitsaktsis
Constantine Bitsaktsis
Jessica A CottrellJessica A Cottrell
Jessica A Cottrell

1 September 2020 in Bone
Verified
Journal Article
Closed access
SHSarah Hozain
Sarah Hozain
Jessica A CottrellJessica A Cottrell
Jessica A Cottrell

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
RVRichard J. Visconti
Richard J. Visconti
KKKyle Kolaja
Kyle Kolaja
Jessica A CottrellJessica A Cottrell
Jessica A Cottrell
Human myeloma bone disease (MBD) occurs when malignant plasma cells migrate to the bone marrow and commence inimical interactions with stromal cells, disrupting the skeletal remodeling process. The myeloma cells simultaneously suppress osteoblastic bone formation while promoting excessive osteoclastic resorption. This bone metabolism imbalance produces osteolytic lesions that cause chronic bone pain and reduce trabecular and cortical bone structural integrity, and often culminate in pathological fractures. Few bone models exist that enable scientists to study MBD and the effect therapies have on restoring the bone metabolism imbalance. The purpose of this research was to develop a well characterized three-dimensional (3D) bone organoid that could be used to study MBD and current or potential treatment options. First, bone marrow stromal cell–derived osteoblasts (OBs) mineralized an endosteal-like extracellular matrix (ECM) over 21 days. Multiple analyses confirmed the generation of hydroxyapatite (HA)-rich bone-like tissue fragments that were abundant in alkaline phosphatase, calcium, and markers of osteoblastic gene expression. On day 22, bone marrow macrophage (BMM)–derived osteoclasts (OCs) were introduced to enhance the resorptive capability of the model and recapitulate the balanced homeostatic nature of skeletal remodeling. Tartrate-resistant acid phosphatase 5b (TRAcP-5b), type I collagen C-telopeptide (CTX-1), and gene expression analysis confirmed OC activity in the normal 3D organoid (3D in vitro model of normal bonelike fragments [3D-NBF]). On day 30, a human multiple myeloma (MM)–derived plasmacytoma cell line was introduced to the 3D-NBF to generate the 3D-myeloma bone disease organoid (3D-MBD). After 12 days, the 3D-MBD had significantly reduced total HA, increased TRAcP-5b levels, increases levels of CTX-1, and decreased expression of osteoblastic genes. Therapeutic intervention with pharmaceutical agents including an immunomodulatory drug, a bisphosphonate, and monoclonal restored HA content and reduced free CTX-1 in a dose-dependent manner. This osteogenically functional model of MBD provides a novel tool to study biological mechanisms guiding the disease and to screen potential therapeutics. © 2021 American Society for Bone and Mineral Research (ASBMR).